MedTrace Logo

Naloxegol US PMR CV Safety.

NCT02813356 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8800

Last updated 2023-05-15

No results posted yet for this study

Summary

The overall research goal for this study is to provide additional data to characterize the safety of naloxegol in patients aged 18 years and older who do not have a diagnosis of cancer and who are treated with opioids chronically

Conditions

  • Opioid Induced Constipation

Interventions

DRUG

naloxegol

non-interventional study where naloxegol is prescribed during normal clinical practice

DRUG

non-PAMORA

non-interventional study where patients are exposed to non-peripherally acting mu-opioid antagonists during the normal course of clinical practice

Sponsors & Collaborators

  • Valinor Pharma LLC

    lead INDUSTRY

Principal Investigators

  • Beth Nordstrom · Evidera

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-24
Primary Completion
2023-12-31
Completion
2023-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02813356 on ClinicalTrials.gov